![Joachim AIGNER | Manager | Priv.-Doz. Dr. | Ludwig-Maximilians-University of Munich, München | LMU | Technology Transfer Joachim AIGNER | Manager | Priv.-Doz. Dr. | Ludwig-Maximilians-University of Munich, München | LMU | Technology Transfer](https://i1.rgstatic.net/ii/profile.image/277518323077127-1443176932487_Q512/Joachim-Aigner-2.jpg)
Joachim AIGNER | Manager | Priv.-Doz. Dr. | Ludwig-Maximilians-University of Munich, München | LMU | Technology Transfer
![KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Nature Structural & Molecular Biology KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Nature Structural & Molecular Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41594-019-0219-9/MediaObjects/41594_2019_219_Fig1_HTML.png)
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Nature Structural & Molecular Biology
![KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Request PDF KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Request PDF](https://i1.rgstatic.net/publication/332900307_KMT9_monomethylates_histone_H4_lysine_12_and_controls_proliferation_of_prostate_cancer_cells/links/5cd111c192851c4eab87f147/largepreview.png)
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells | Request PDF
![In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study - The Lancet Respiratory Medicine In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/f7ee65ba-6601-411a-929c-dce340c52473/gr1.jpg)